Bayesian Capital Management, LP Adamas Pharmaceuticals, Inc. Transaction History
Bayesian Capital Management, LP
- $838 Million
- Q3 2024
About Adamas Pharmaceuticals, Inc.
- Ticker ADMS
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,408,100
- Market Cap $376M